Related Experiment Videos
Serum interleukin-1 beta is increased in cluster headache
P Martelletti1, M Granata, M Giacovazzo
1Headache Centre, University La Sapienza, Rome, Italy.
Insights
Serum interleukin-1 beta (IL-1 beta) levels are elevated in cluster headache (CH) patients, indicating immune system activation. This inflammatory marker increases further during CH attacks compared to between attacks and healthy individuals.
Area of Science:
- Neuroscience
- Immunology
Background:
- Cluster headache (CH) is a debilitating neurological disorder.
- The role of inflammation in CH pathophysiology is not fully understood.
Purpose of the Study:
- To investigate serum levels of interleukin-1 beta (IL-1 beta) in episodic CH patients.
- To determine if IL-1 beta levels correlate with CH attack phases.
Main Methods:
- Serum IL-1 beta was measured using a specific enzyme-linked immunosorbent assay (ELISA).
- 24 episodic CH patients and 45 healthy controls were included.
Main Results:
- Elevated serum IL-1 beta was observed in all CH patients compared to controls.
- IL-1 beta levels were significantly higher in CH patients between attacks compared to controls.
- IL-1 beta levels were further elevated during the ictal phase of CH compared to between attacks and controls.
Conclusions:
- These findings suggest an activated immune system in CH.
- IL-1 beta may play a role in the pathophysiology of cluster headache.
Abstract:
We measured serum interleukin-1 beta (IL-1 beta) in 24 episodic cluster headache (CH) patients and 45 normal controls using a specific ELISA method. There was an increase in IL-1 beta in all CH patients compared to controls. IL-1 beta was further increased during the ictal phase of CH compared to patients between attacks and normal individuals. Between attacks, IL-1 beta was also significantly increased compared to controls. We suggest that these results represent an activation of the immune system in CH.